Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

January 1, 1997; Volume 38,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Lanning, B. Marjatta

    1. You have access
      Brain Perfusion after Treatment of Childhood Acute Lymphoblastic Leukemia
      Arja H. Harila-Saari, Aapo K.A. Ahonen, Leena K. Vainionpää, Eija L. Pääkkö, Juhani Pyhtinen, A. Sinikka Himanen, Pentti J. Torniainen and B. Marjatta Lanning
      Journal of Nuclear Medicine January 1, 1997, 38 (1) 82-88;
  2. Larsen, Scott K.

    1. You have access
      Tumor Imaging with Technetium-99m-Labeled Hydrazinonicotinamide-Fab′ Conjugates
      Michiel E. Ultee, Gary J. Bridger, Michael J. Abrams, Clifford B. Longley, Charlotte A. Burton, Scott K. Larsen, Geoffrey W. Henson, Sreenivasan Padmanabhan, Forrest E. Gaul and David A. Schwartz
      Journal of Nuclear Medicine January 1, 1997, 38 (1) 133-138;
  3. Lee, Myung Chul

    1. You have access
      Crossed-Cerebellar Diaschisis in Cerebral Infarction: Technetium-99m-HMPAO SPECT and MRI
      Sang Eun Kim, Chang Woon Choi, Byung-Woo Yoon, June-Key Chung, Jae Kyu Roh, Myung Chul Lee and Chang-Soon Koh
      Journal of Nuclear Medicine January 1, 1997, 38 (1) 14-19;
  4. Lind, Peter

    1. You have access
      Technetium-99m-MIBI Scintigraphy of Thyroid Nodules in an Endemic Goiter Area
      Ewald Kresnik, Hans-Jürgen Gallowitsch, Peter Mikosch, Iris Gomez and Peter Lind
      Journal of Nuclear Medicine January 1, 1997, 38 (1) 62-65;
  5. Line, Bruce R.

    1. You have access
      Diagnostic Test Comparisons in Patients with Deep Venous Thrombosis
      Bruce R. Line, Teresa L. Peters and James Keenan
      Journal of Nuclear Medicine January 1, 1997, 38 (1) 89-92;
  6. Lister-james, John

    1. You have access
      Pre-Clinical Evaluation of Technetium-99m Platelet Receptor-Binding Peptide
      John Lister-James, Shankar Vallabhajosula, Brian R. Moyer, Daniel A. Pearson, Bill J. McBride, Mark A. De Rosch, Larry R. Bush, Josef Machac and Richard T. Dean
      Journal of Nuclear Medicine January 1, 1997, 38 (1) 105-111;
  7. Liu, Hong-Gang

    1. You have access
      Regional Stability of Cerebral Blood Flow Measured by Repeated Technetium-99m-HMPAO SPECT: Implications for the Study of State-Dependent Change
      Georg Deutsch, James M. Mountz, Charles R. Katholi, Hong-Gang Liu and Lindy E. Harrell
      Journal of Nuclear Medicine January 1, 1997, 38 (1) 6-13;
  8. Longley, Clifford B.

    1. You have access
      Tumor Imaging with Technetium-99m-Labeled Hydrazinonicotinamide-Fab′ Conjugates
      Michiel E. Ultee, Gary J. Bridger, Michael J. Abrams, Clifford B. Longley, Charlotte A. Burton, Scott K. Larsen, Geoffrey W. Henson, Sreenivasan Padmanabhan, Forrest E. Gaul and David A. Schwartz
      Journal of Nuclear Medicine January 1, 1997, 38 (1) 133-138;
  9. Machac, Josef

    1. You have access
      Pre-Clinical Evaluation of Technetium-99m Platelet Receptor-Binding Peptide
      John Lister-James, Shankar Vallabhajosula, Brian R. Moyer, Daniel A. Pearson, Bill J. McBride, Mark A. De Rosch, Larry R. Bush, Josef Machac and Richard T. Dean
      Journal of Nuclear Medicine January 1, 1997, 38 (1) 105-111;
  10. Mackey, Douglas W.J.

    1. You have access
      Physical Properties and Use of Pertechnegas as a Ventilation Agent
      Douglas W.J. Mackey, Phillip Jackson, Richmond J. Baker, Con Dasaklis, Keith J. Fisher, Michael Magee, Vivienne Bush, William M. Burch, Hans Van der Wall and Gary D. Willett
      Journal of Nuclear Medicine January 1, 1997, 38 (1) 163-167;
« Previous (Pages : 8 9 10 11 12 13 14 15 16 17 ... 22) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 38, Issue 1
January 1, 1997
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire